Facts are facts, regardless of what other companies may be telling you. In gaining approval from the U.S. Food and Drug Administration (FDA), Macrosyn™ was granted the same label claims as Draxxin® and is bioequivalent to the pioneer product in:
- Active ingredient & inactive ingredients (including carriers and excipients)
- Strength, dosage form & route of administration
Additionally, Macrosyn meets the same quality and safety requirements and is manufactured at an approved FDA facility.
See How Macrosyn Stacks Up Against Draxxin
*See label for complete product information.Draxxin is a registered trademark of Zoetis Inc.